Qfitlia works in a novel way by lowering antithrombin1,2

Antithrombin activity levels can be reliably measured.1,3


Qfitlia is an siRNA therapy that targets antithrombin and enables low treatment frequency, subcutaneous dosing, and low-volume injection.1,2
Watch this video to view the mechanism of action for Qfitlia
MOA=mechanism of action.
References
-
Qfitlia Prescribing Information. Genzyme Corporation. Cambridge, MA.
-
Machin N, et al. J Blood Med. 2018;9:135-140.
-
Advate Prescribing Information. Takeda Pharmaceuticals U.S.A., Inc. Lexington, MA.
-
Adynovate Prescribing Information. Takeda Pharmaceutical U.S.A., Inc. Lexington, MA.
-
Afstyla Prescribing Information. CSL Behring LLC. Kankakee, IL.
-
ALTUVIIIO Prescribing Information. Bioverativ Therapeutics Inc. Waltham, MA.
-
Esperoct Prescribing Information. Novo Nordisk Inc. Plainsboro, NJ.
-
Helixate Prescribing Information. CSL Behring LLC. Kankakee, IL.
-
Hemlibra Prescribing Information. Genentech, Inc. San Francisco, CA.
-
Jivi Prescribing Information. Bayer HealthCare LLC. Whippany, NJ.
-
Kogenate Prescribing Information. Bayer HealthCare LLC. Whippany, NJ.
-
Kovaltry Prescribing Information. Bayer HealthCare LLC. Whippany, NJ.
-
Novoeight Prescribing Information. Novo Nordisk Inc. Plainsboro, NJ.
-
Nuwiq Prescribing Information. Octapharma USA, Inc. Paramus, NJ.
-
Xyntha Prescribing Information. Wyeth Pharmaceuticals LLC. Philadelphia, PA.